Navigation Links
Zeltiq Aesthetics Names Gordie Nye to Serve as New CEO
Date:9/29/2009

PLEASANTON, Calif., Sept. 29 /PRNewswire/ -- Zeltiq Aesthetics, a science-based medical device company dedicated to the development of non-invasive procedures for the reduction of unwanted fat tissue, has announced the appointment of Gordie Nye as its new CEO. Mr. Nye succeeds Mitch Levinson, the founder of Zeltiq Aesthetics, who served as President since September 2005, and as Chief Executive Officer and a member of the Board of Directors since 2006. Mr. Levinson will continue as a key member of the senior executive team.

Gordie Nye brings over 25 years of senior management and operational expertise to Zeltiq Aesthetics. During his career, Mr. Nye has demonstrated outstanding leadership skills, and has both deep life sciences and consumer marketing experience.

In 2003, Mr. Nye joined Prism VentureWorks as a General Partner in its life sciences investment team where he focused on medical devices. During this time, he served on the boards of several Prism portfolio companies and will remain active as a Director of certain select Prism companies.

"We are very excited to have Gordie on board signaling the transition of Zeltiq to a commercial enterprise. Mitch did an exceptional job shepherding this revolutionary approach through product development, and now we are ready to establish Zeltiq as the premier technology brand in the aesthetic market," said Director Nathan Every, MD, MPH, of Frazier Healthcare Ventures.

Prior to joining Prism, Mr. Nye served as a Director, early stage investor, and CEO of REVA Medical, Inc., the developer of a novel resorbable, drug-eluting stent for the interventional cardiology market. In 1998, Mr. Nye and colleagues at Group Outcome joined with Liberty Partners to acquire Critikon, the patient monitoring unit of Johnson & Johnson. There, he served as President and CEO and led a comprehensive product line overhaul. GE Medical Systems acquired Critikon in 2000. Mr. Nye was also President, CEO and Director of "A" Company, a premier brand in the orthodontic appliance market. As with Critikon, Mr. Nye presided over a product line overhaul and eventual sale to Sybron International (now part of Danaher).

Prior to moving into the medical technology industry, Mr. Nye spent nearly 15 years in the consumer packaged goods & leisure business in a variety of marketing, sales and general management roles for companies including Gillette, Olin Ski Company, Reebok and L.A. Gear.

"I am thrilled to join Zeltiq because I can draw from my experience in relevant consumer products and medical technology businesses to propel the company through its commercial phase," said Mr. Nye. "With its advanced cooling technology for fat layer reduction, best-in-class engineering, exceptional talent and superb physician relationships, we hope to position Zeltiq as the most scientifically rigorous and innovative company in the medical aesthetics market."

About Zeltiq Aesthetics

Zeltiq Aesthetics, founded in 2005, is a science-based medical device company dedicated to the development of non-invasive procedures for the reduction of unwanted fat tissue. The initial Cryolipolysis research and patents were originated at The Wellman Center by Dr. Dieter Manstein and Dr. R. Rox Anderson. Zeltiq has exclusive rights to this innovative new approach to removing fat.

The Zeltiq Procedure is cleared by Health Canada and the European Union for non-invasive fat layer reduction through cold-assisted lipolysis and is available for sale to physicians on a limited basis in the European Union, Canada, the USA, and other select international markets. The Zeltiq device is also cleared by the U.S. FDA for various applications related to skin cooling during dermatologic treatments, with a pending application for non-invasive fat layer reduction. For more information, please visit www.zeltiq.com

SOURCE Zeltiq Aesthetics


'/>"/>
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Accent on Aesthetics Plastic Surgery Medical Center Selects Artefill to Meet Growing Patient Demand for a Longer Lasting Dermal Filler
2. California Cryobank Names Richard Jennings President of FamilyCord Division
3. Association of Clinical Research Organizations (ACRO) Names Dr. Derek Winstanly Chair-Elect
4. PLC Medical Systems Names Lead Investigators for Pivotal Trial to Evaluate RenalGuard System(TM) and RenalGuard Therapy(TM)
5. Xytis Names Gordon H. Busenbark as Chief Financial Officer
6. Global HIV Vaccine Enterprise Names Alan Bernstein as Inaugural Executive Director, Opens New Secretariat
7. AIDS Healthcare Foundation Names Homayoon Khanlou, M.D. as its Chief of Medicine, U.S.
8. Dr. Derek Winstanly of Quintiles to Serve as 2009 ACRO Chair; Mr. William Sharbaugh of PPD to Be Chair-Elect
9. Photos: SOS Childrens Villages Observes World Orphan Week, October 5-11, 2008
10. BioNumerik Pharmaceuticals Observes Evidence of a Survival Increase in Lung Cancer Patients Participating in Tavocept(TM) Clinical Trial
11. Snapshots of Eyes Could Serve as Early Warning of Diabetes or Diabetic Eye Disease, U-M Researchers Report
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... , Oct. 12, 2017 AVACEN Medical , ... company with their  2017 New Product Innovation Award for ... extensive primary and secondary medical device market research by Frost ... its first-to-market OTC, drug-free pain relief product, the AVACEN 100, ... to treating fibromyalgia widespread pain. ...
(Date:10/11/2017)...  Caris Life Sciences ® , a leading innovator ... precision medicine, today announced that St. Jude Medical Center,s ... (POA) as its 17 th member. Through participation ... Cancer Institute will help develop standards of care and ... making cancer treatment more precise and effective. ...
(Date:10/10/2017)... EXTON, Pa. , Oct. 10, 2017   ... leader in innovative solutions for injectable drug administration, today ... of West,s ID Adapter for improving the intradermal administration ... the Fourth Skin Vaccination Summit in May 2017 by ... Team Lead, Polio Department, World Health Organization (WHO), and ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... October 13, 2017 , ... PurhealthRX , a leading Health and Nutrition ... the Purzorb™process to full spectrum CBD oil will revolutionize the rapidly growing CBD market ... can be easily incorporated into liquid products, while reducing costs to end users. , ...
(Date:10/13/2017)... , ... October 13, 2017 , ... The Visiting Nurse ... Market. Featuring a collection of specialty vendors and unique items from across the nation, ... quality-focused health and wellness services offered by the VNA. The boutique will be ...
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... ... DevOps and Agile Software Development, has been awarded a contract by the Center ... Purchase Agreement (BPA) aims to accelerate the enterprise use of Agile methodologies in ...
(Date:10/12/2017)... ... ... Planet Fitness, one of the largest and fastest growing franchisors and operators ... location in Covington, LA at 401 N. U.S. Highway 190, in January of 2018. ... in the Holiday Square shopping center. Its location allows it to serve both Covington ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information about the technology: ... develop to enable prevention of a major side effect of chemotherapy in children. ... pediatric patients. For cisplatin, hearing loss is FDA listed on-label as a dose ...
Breaking Medicine News(10 mins):